Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2019

Feb 28, 2019

32227_dirs_2019-02-28_4174eacc-71ca-408a-83c9-4faa3e04b20a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-02-26

Reporting Person: Bonello William (Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-26 Common Stock M 40166 $8.03 Acquired 40166 Direct
2019-02-26 Common Stock M 20037 $7.52 Acquired 60203 Direct
2019-02-26 Common Stock S 60203 $18.90 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-26 Stock Option (Right to Buy) $8.03 M 40166 Disposed 2023-02-26 Common Stock (40166.0) Direct
2019-02-26 Stock Option (Right to Buy) $7.52 M 20037 Disposed 2022-04-28 Common Stock (20037.0) Direct